Wilmington Savings Fund Society’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Wilmington Savings Fund Society’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.4K	Hold	91	–	–	﹤0.01%	1133
2026 Q1	$11.6K	Hold	91	–	–	﹤0.01%	1164
2025 Q4	$11.1K	Buy	91 +61	+203%	+$6.99K	﹤0.01%	1161
2025 Q3	$3.01K	Sell	30 -1,988	-99%	-$179K	﹤0.01%	1278
2025 Q2	$167K	Sell	2,018 -3,216	-61%	-$257K	﹤0.01%	858
2025 Q1	$424K	Hold	5,234	–	–	0.01%	613
2024 Q4	$471K	Hold	5,234	–	–	0.01%	608
2024 Q3	$517K	Buy	+5,234	New	+$514K	0.01%	566

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Wilmington Savings Fund Society's XBI Position: Q2 2026 in Review

Wilmington Savings Fund Society held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 91 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1133.

Wilmington Savings Fund Society first reported a position in XBI in Q3 2024 and has held it in 8 quarters since. The position peaked at $517K in Q3 2024. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Wilmington Savings Fund Society held 91 shares of State Street SPDR S&P Biotech ETF worth $14.4K as of Q2 2026.
Wilmington Savings Fund Society left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1133 holding.
Wilmington Savings Fund Society first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and has held it in 8 quarters since.
Wilmington Savings Fund Society's State Street SPDR S&P Biotech ETF position peaked at $517K in Q3 2024.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.